U-251 revisited: Genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells

Cancer Medicine

Volumn 3, Issue 4, 2014, Pages 812-824

  Torsvik, Anja ^a   Stieber, Daniel ^b   Enger, PerØyvind ^a,c   Golebiewska, Anna ^b   Molven, Anders ^a,c   Svendsen, Agnete ^a   Westermark, Bengt ^d   Niclou, Simone P ^b   Olsen, Thale Kristin ^e   Chekenya Enger, Martha ^a   Bjerkvig, Rolf ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UPPSALA UNIVERSITY   (Sweden)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

ACGH; Cell lines; Cross contamination; GBM; In vitro models; STR; U251; U373

Indexed keywords

CELL SURFACE MARKER; GENOMIC DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CLONOGENIC ASSAY; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA FINGERPRINTING; GENE DOSAGE; GENE EXPRESSION; GENETIC DRIFT; GENOTYPE; GLIOBLASTOMA CELL LINE; GROWTH RATE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPE; KARYOTYPING; MOLECULAR CLONING; MORPHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PLOIDY; PRIORITY JOURNAL; U-251 CELL LINE; ANIMAL; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL SHAPE; FEMALE; GLIOBLASTOMA; HUMAN; MALE; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE EXPRESSION; GENETIC DRIFT; GLIOBLASTOMA; HUMANS; KARYOTYPE; MALE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; PHENOTYPE; PLOIDIES;

EID: 84920813556     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.219     Document Type: Article

References (26)

1. Ponten, J., and B. Westermark . 1978. Properties of human malignant glioma cells in vitro. Med. Biol. 56:184-193.
2. Westermark, B., J. Ponten, and R. Hugosson . 1973. Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol. Microbiol. Scand. A 81:791-805.
3. Ponten, J., and E. H. Macintyre . 1968. Long term culture of normal and neoplastic human glia. Acta Pathol. Microbiol. Scand. 74:465-486.
4. Nister, M., T. A. Libermann, C. Betsholtz, M. Pettersson, L. Claesson-Welsh, C. H. Heldin, et al. 1988. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res. 48:3910-3918.
5. Ishii, N., D. Maier, A. Merlo, M. Tada, Y. Sawamura, A. C. Diserens, et al. 1999. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 9:469-479.
6. Fuxe, J., G. Akusjarvi, H. M. Goike, G. Roos, V. P. Collins, and R. F. Pettersson . 2000. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A. Cell Growth Differ. 11:373-384.
7. Azari, S., N. Ahmadi, M. J. Tehrani, and F. Shokri . 2007. Profiling and authentication of human cell lines using short tandem repeat (STR) loci: report from the National Cell Bank of Iran. Biologicals 35:195-202.
8. Capes-Davis, A., G. Theodosopoulos, I. Atkin, H. G. Drexler, A. Kohara, R. A. MacLeod, et al. 2010. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int. J. Cancer 127:1-8.
9. Chatterjee, R. 2009. Cell biology. Cases of mistaken identity. Science 315:928-931.
10. Editorial. 2009. Identity crisis. Nature 457:935-936.
11. ASN-0002 ATCCSDOW. 2010. Cell line misidentification: the beginning of the end. Nat. Rev. Cancer 10:441-448.
12. Mandahl, N. 2001. Methods in solid tumor cytogenetics. Pp. 165-203 in D. E. Rooney, ed. Human Cytogenetics - a practical approach: malignancy and acquired abnormalities. Vol. II. Oxford University Press, Oxford, U.K.
13. Franken, N. A., H. M. Rodermond, J. Stap, J. Haveman, and C. van Bree . 2006. Clonogenic assay of cells in vitro. Nat. Protoc. 1:2315-2319.
14. Lorenzi, P. L., W. C. Reinhold, S. Varma, A. A. Hutchinson, Y. Pommier, S. J. Chanock, et al. 2005. DNA fingerprinting of the NCI-60 cell line panel. Mol. Cancer Ther. 8:713-724.
15. Parson, W., R. Kirchebner, R. Muhlmann, K. Renner, A. Kofler, S. Schmidt, et al. 2005. Cancer cell line identification by short tandem repeat profiling: power and limitations. FASEB J. 19:434-436.
16. Poetsch, M., A. Petersmann, C. Woenckhaus, C. Protzel, T. Dittberner, E. Lignitz, et al. 2004. Evaluation of allelic alterations in short tandem repeats in different kinds of solid tumors-possible pitfalls in forensic casework. Forensic Sci. Int. 145:1-6.
17. Masters, J. R., J. A. Thomson, B. Daly-Burns, Y. A. Reid, W. G. Dirks, P. Packer, et al. 2001. Short tandem repeat profiling provides an international reference standard for human cell lines. Proc. Natl Acad. Sci. USA 98:8012-8017.
18. Li, A., J. Walling, Y. Kotliarov, A. Center, M. E. Steed, S. J. Ahn, et al. 2008. Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas. Mol. Cancer Res. 6:21-30.
19. Beroukhim, R., G. Getz, L. Nghiemphu, J. Barretina, T. Hsueh, D. Linhart, et al. 2007. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl Acad. Sci. USA 104:20007-20012.
20. Greshock, J., K. Nathanson, A. M. Martin, L. Zhang, G. Coukos, B. L. Weber, et al. 2007. Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization. Cancer Res. 67:3594-3600.
21. Joensuu, H., M. Puputti, H. Sihto, O. Tynninen, and N. N. Nupponen . 2005. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme. J. Pathol. 207:224-231.
22. Holtkamp, N., N. Ziegenhagen, E. Malzer, C. Hartmann, A. Giese, and A. von Deimling . 2007. Characterization of the amplicon on chromosomal segment 4q12 in glioblastoma multiforme. Neuro. Oncol. 9:291-297.
23. Kanu, O. O., B. Hughes, C. Di, N. Lin, J. Fu, D. D. Bigner, et al. 2009. Glioblastoma multiforme oncogenomics and signaling pathways. Clin. Med. Oncol. 3:39-52.
24. De Witt Hamer, P. C., A. A. Van Tilborg, P. P. Eijk, P. Sminia, D. Troost, C. J. Van Noorden, et al. 2008. The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene 27:2091-2096.
25. Gillet, J. P., A. M. Calcagno, S. Varma, M. Marino, L. J. Green, M. I. Vora, et al. 2004. Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc. Natl. Acad. Sci. USA 108:18708-18713.
26. Lacroix, M., and G. Leclercq . 2004. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res. Treat. 83:249-289.